InterCure Ltd. (NASDAQ:INCR) Short Interest Down 21.9% in October

InterCure Ltd. (NASDAQ:INCRGet Free Report) was the recipient of a large drop in short interest during the month of October. As of October 31st, there was short interest totalling 13,900 shares, a drop of 21.9% from the October 15th total of 17,800 shares. Based on an average daily trading volume, of 28,600 shares, the short-interest ratio is presently 0.5 days. Currently, 0.1% of the company’s shares are sold short.

InterCure Stock Down 5.9 %

Shares of INCR stock traded down $0.07 on Friday, reaching $1.17. 142,958 shares of the stock were exchanged, compared to its average volume of 37,305. The company has a current ratio of 1.78, a quick ratio of 1.15 and a debt-to-equity ratio of 0.15. InterCure has a one year low of $1.06 and a one year high of $3.72. The stock has a 50 day moving average price of $1.76 and a 200 day moving average price of $2.21.

Institutional Inflows and Outflows

A number of large investors have recently added to or reduced their stakes in the business. Tidal Investments LLC acquired a new stake in shares of InterCure during the 1st quarter worth approximately $883,000. AdvisorShares Investments LLC acquired a new stake in InterCure during the 2nd quarter worth $218,000. Jane Street Group LLC acquired a new stake in InterCure during the 3rd quarter worth $49,000. Finally, Renaissance Technologies LLC raised its position in shares of InterCure by 30.9% during the 2nd quarter. Renaissance Technologies LLC now owns 45,300 shares of the company’s stock valued at $91,000 after acquiring an additional 10,700 shares during the last quarter. 8.34% of the stock is currently owned by institutional investors and hedge funds.

InterCure Company Profile

(Get Free Report)

InterCure Ltd., together with its subsidiaries, engages in the research, cultivation, production, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use in Israel and internationally. The company offers dried cannabis inflorescences and cannabis extract mixed with oil.

Further Reading

Receive News & Ratings for InterCure Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for InterCure and related companies with MarketBeat.com's FREE daily email newsletter.